Patents by Inventor Stefan Werner Schneider

Stefan Werner Schneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040097583
    Abstract: Inhibitors of the cellular sodium/hydrogen exchangers show an inhibiting effect on the secretion of von-Willebrand factor and/or increased expression of P-selectin. These inhibitors can therefore be employed for the treatment of thrombotic and inflammatory disorders.
    Type: Application
    Filed: February 7, 2003
    Publication date: May 20, 2004
    Inventors: Hans-Jochen Lang, Stefan Werner Schneider, Hans Oberleithner, Andre Niemeyer
  • Publication number: 20030220383
    Abstract: Inhibitors of the cellular sodium-dependent chloride/bicarbonate exchangers show an inhibiting effect on the secretion of von-Willebrand factor. These inhibitors can therefore be employed for the treatment of thrombotic and inflammatory disorders.
    Type: Application
    Filed: February 14, 2003
    Publication date: November 27, 2003
    Applicant: AVENTIS PHARMA DEUTSCHLAND GMBH
    Inventors: Hans-Jochen Lang, Heinz-Werner Kleemann, Stefan Werner Schneider, Hans Oberleithner, Andre Niemeyer
  • Patent number: D427414
    Type: Grant
    Filed: September 4, 1998
    Date of Patent: July 4, 2000
    Assignee: Kraft Jacobs Suchard R&D, Inc.
    Inventors: Claude Andre Despland, Caroline Dominique Rey, Stefan Werner Schneider, Neil David Jarvis